Organigram Global Inc. (OGI) Earnings Call Transcripts
Organigram Global Inc.'s Latest Earnings Call - March 30, 2026
The earnings call for Organigram Global Inc. for the fiscal year ended September 30, 2025, primarily focused on corporate governance matters, including the election of directors and the appointment of auditors. No specific financial results such as revenue or earnings were discussed, nor were any changes to guidance mentioned. The meeting also covered resolutions related to equity incentive plans and a significant acquisition, which could impact future growth prospects.
Reported metrics
| Metric | Value |
|---|---|
| Election of Directors | 10 directors elected (inline) |
| Appointment of Auditors | PricewaterhouseCoopers LLP (neutral) |
| Equity Incentive Plan | Approved (neutral) |
| Acquisition Approval | Approved (positive) |
What management said
Mr. Chairman, I move that each of the 10 persons nominated be hereby elected as directors of Organigram to hold office until the next Annual Meeting of Shareholders or until they resign or their successors are elected or appointed.
I move that PricewaterhouseCooper LLP, chartered accounting at Toronto office located at 18 York Street, Suite 2500, Toronto be appointed as auditor of the company to hold office until the close of the next Annual Meeting of Shareholders or until the successor is appointed and that the directors be authorized to fix their remuneration.
What analysts pressed on
Analysts may be concerned about the lack of specific financial guidance and the implications of the acquisition on the company's balance sheet and future earnings potential.
Main topics on the call
- Election of Directors — The company successfully elected 10 directors, including new CEO James Yamanaka, to serve until the next annual meeting. This continuity in leadership is expected to maintain strategic direction.
- Appointment of Auditors — PricewaterhouseCoopers LLP was appointed as the new auditor, replacing PKF O'Connor Davies, LLP. This change could imply a shift in financial oversight or strategy.
- Equity Incentive Plan Approval — Shareholders approved the ordinary resolution for unallocated options, restricted share units, performance share units, and deferred share units under the company's long-term omnibus equity incentive plan.
- Acquisition of Sanity Group GmbH — An ordinary resolution was passed to approve the acquisition of Sanity Group GmbH and the issuance of up to 96,287,602 common shares. This acquisition is a strategic move to expand Organigram's market presence.
Read the full Organigram Global Inc. transcript (March 30, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Organigram Global Inc.
Organigram Global Inc. (OGI) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 32 calls on record spanning January 14, 2020 to August 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 32 Organigram Global Inc. earnings call transcripts on record, spanning January 14, 2020 to August 11, 2026. Based on this history, Organigram Global Inc. reports quarterly. The most recent call on file is dated August 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- OGI
- Exchange
- TSX
- Country
- CA
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 32
- First call
- January 14, 2020
- Most recent
- August 11, 2026
- Reporting cadence
- quarterly